SNT 9.09% 2.4¢ syntara limited

Ann: Preliminary Final Report, page-2

  1. 5,627 Posts.
    lightbulb Created with Sketch. 665
    https://www.pharmaceutical-technology.com/comment/current-future-cystic-fibrosis-market/?cf-view

    Vertex has unbelievable market share in cystic fibrosis treatment

    But at least Pharmaxis is well recognised

    keep up the good work Pharmaxis!!!
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.002(9.09%)
Mkt cap ! $26.26M
Open High Low Value Volume
2.4¢ 2.4¢ 2.4¢ $1.996K 83.16K

Buyers (Bids)

No. Vol. Price($)
1 1250000 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 100000 1
View Market Depth
Last trade - 10.10am 04/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.